According to Stratistics MRC, the Global In Vitro Diagnostics market is accounted for $61.65 billion in 2015 and is expected to reach $94.57 billion by 2022 growing at a CAGR of 6.3%. Technologically advanced healthcare and consumer spending in market is helping the market growth. Polluted environment and contaminated surroundings are leading to increase in number of chronic disease and infections, these all factors are favoring the market to grow. Moreover widely spread knowledge and cost effectiveness are also driving the market. But stringent regulations and reimbursement issues are hampering the market growth.
However Infectious disease in application segment is anticipated to grow at considerable pace due to rise in amount of infectious diseases and it is followed by HIV/AIDS application. Whereas Laboratories in end-user segment is estimated to grow fast because of rise in number of laboratories, followed by Point of Care Diagnostics. North America being the largest revenue market, Asia Pacific is expected to grow fast due to increasing number of End-User applications.
Some of the major key players in the market are Roche Diagnostics Bio-Rad Laboratories, Inc., Johnson and Johnson , Biomérieux, Siemens Healthcare, Abbott Laboratories, Inc., Thermo Fisher Scientific, Inc., Ortho Clinical Diagnostics, Inc., Danaher Corporation, Sysmex Corporation, Becton, Dickinson and Company, Cepheid Inc , Alere Inc., Novartis and Leica Biosystems.
Applications Covered:
• Diabetes
• Autoimmune Diseases
• Cardiology
• Drug Testing
• HIV/AIDS
• Infectious Diseases
• Nephrology
• Oncology/Cancer
• Other Applications
Product & Services Covered:
• Data Management Software/Hardware
• Instruments
• Reagents & Kits
• Services
Technologies Covered:
• Immunochemistry/Immunoassays
o Elisa
? Chemiluminescence Immunoassays (CLIAs)
? Colorimetric Immunoassays (CI)
? Fluorescence Immunoassays (FIA)
o Western Blot
o Rapid Tests
o Radioimmunoassay’s (RIA)
o Elispot
• Coagulation and Hemostasis
• Molecular Diagnostics (MDX)
o DNA Sequencing & Next-Generation Sequencing
o Hybridization
o Isothermal Nucleic Acid Amplification Technology (INAAT)
o Microarrays
o Polymerase Chain Reaction (PCR)
o Other Molecular Diagnostics
• Hematology
• Microbiology
• Clinical Chemistry
o Electrolyte Panels
o Basic Metabolic Panel
o Lipid Profiles
o Liver Panels
o Renal Profiles
o Specialty Chemical Tests
o Thyroid Function Panels
• Other Technologies
End-Users Covered:
• Academic Institutes
• Hospitals
• Laboratories
• Patient Self-Testing
• Point-Of-Care Testing
• Other End-Users
Regions Covered:
• North America
o US
o Canada
o Mexico
• Europe
o Germany
o France
o Italy
o UK
o Spain
o Rest of Europe
• Asia Pacific
o Japan
o China
o India
o Australia
o New Zealand
o Rest of Asia Pacific
• Rest of the World
o Middle East
o Brazil
o Argentina
o South Africa
o Egypt
What our report offers:
- Market share assessments for the regional and country level segments
- Market share analysis of the top industry players
- Strategic recommendations for the new entrants
- Market forecasts for a minimum of 7 years of all the mentioned segments, sub segments and the regional markets
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements
1 Executive Summary
2 Preface
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions
3 Market Trend Analysis
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Application Analysis
3.7 Product Analysis
3.8 Technology Analysis
3.9 End-User Analysis
3.10 Emerging Markets
4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry
5 Global In Vitro Diagnostics Market, By Application
5.1 Introduction
5.2 Diabetes
5.3 Autoimmune Diseases
5.4 Cardiology
5.5 Drug Testing
5.6 HIV/AIDS
5.7 Infectious Diseases
5.8 Nephrology
5.9 Oncology/Cancer
5.10 Other Applications
6 Global In Vitro Diagnostics Market, By Product & Service
6.1 Introduction
6.2 Data Management Software/Hardware
6.3 Instruments
6.4 Reagents & Kits
6.5 Services
7 Global In Vitro Diagnostics Market, By Technology
7.1 Introduction
7.2 Immunochemistry/Immunoassays
7.2.1 Elisa
7.2.1.1 Chemiluminescence Immunoassays (CLIAs)
7.2.1.2 Colorimetric Immunoassays (CI)
7.2.1.3 Fluorescence Immunoassays (FIA)
7.2.2 Western Blot
7.2.3 Rapid Tests
7.2.4 Radioimmunoassays (RIA)
7.2.5 Elispot
7.3 Coagulation and Hemostasis
7.4 Molecular Diagnostics (MDX)
7.4.1 DNA Sequencing & Next-Generation Sequencing
7.4.2 Hybridization
7.4.3 Isothermal Nucleic Acid Amplification Technology (INAAT)
7.4.4 Microarrays
7.4.5 Polymerase Chain Reaction (PCR)
7.4.6 Other Molecular Diagnostics
7.5 Hematology
7.6 Microbiology
7.7 Clinical Chemistry
7.7.1 Electrolyte Panels
7.7.2 Basic Metabolic Panel
7.7.3 Lipid Profiles
7.7.4 Liver Panels
7.7.5 Renal Profiles
7.7.6 Specialty Chemical Tests
7.7.7 Thyroid Function Panels
7.8 Other Technologies
8 Global In Vitro Diagnostics Market, By End-User
8.1 Introduction
8.2 Academic Institutes
8.3 Hospitals
8.4 Laboratories
8.5 Patient Self-Testing
8.6 Point-Of-Care Testing
8.7 Other End-Users
9 Global In Vitro Diagnostics Market, By Geography
9.1 North America
9.1.1 US
9.1.2 Canada
9.1.3 Mexico
9.2 Europe
9.2.1 Germany
9.2.2 France
9.2.3 Italy
9.2.4 UK
9.2.5 Spain
9.2.6 Rest of Europe
9.3 Asia Pacific
9.3.1 Japan
9.3.2 China
9.3.3 India
9.3.4 Australia
9.3.5 New Zealand
9.3.6 Rest of Asia Pacific
9.4 Rest of the World
9.4.1 Middle East
9.4.2 Brazil
9.4.3 Argentina
9.4.4 South Africa
9.4.5 Egypt
10 Key Developments
10.1 Agreements, Partnerships, Collaborations and Joint Ventures
10.2 Acquisitions & Mergers
10.3 New Product Launch
10.4 Expansions
10.5 Other Key Strategies
11 Company Profiling
11.1 Roche Diagnostics
11.2 Bio-Rad Laboratories, Inc.
11.3 Johnson and Johnson
11.4 Biomérieux
11.5 Siemens Healthcare
11.6 Abbott Laboratories, Inc.
11.7 Thermo Fisher Scientific, Inc.
11.8 Ortho Clinical Diagnostics, Inc.
11.9 Danaher Corporation
11.10 Sysmex Corporation
11.11 Becton, Dickinson and Company
11.12 Cepheid Inc
11.13 Alere Inc.
11.14 Novartis
11.15 Leica Biosystems
Table of Contents
1 Global In Vitro Diagnostics Market Outlook, By Region (2013-2022) ($MN)
2 Global In Vitro Diagnostics Market Outlook, By Application (2013-2022) ($MN)
3 Global In Vitro Diagnostics Market Outlook, By Diabetes (2013-2022) ($MN)
4 Global In Vitro Diagnostics Market Outlook, By Autoimmune Diseases (2013-2022) ($MN)
5 Global In Vitro Diagnostics Market Outlook, By Cardiology (2013-2022) ($MN)
6 Global In Vitro Diagnostics Market Outlook, By Drug Testing (2013-2022) ($MN)
7 Global In Vitro Diagnostics Market Outlook, By HIV/AIDS (2013-2022) ($MN)
8 Global In Vitro Diagnostics Market Outlook, By Infectious Diseases (2013-2022) ($MN)
9 Global In Vitro Diagnostics Market Outlook, By Nephrology (2013-2022) ($MN)
10 Global In Vitro Diagnostics Market Outlook, By Oncology/Cancer (2013-2022) ($MN)
11 Global In Vitro Diagnostics Market Outlook, By Other Applications (2013-2022) ($MN)
12 Global In Vitro Diagnostics Market Outlook, By Product & Service (2013-2022) ($MN)
13 Global In Vitro Diagnostics Market Outlook, By Data Management Software/Hardware (2013-2022) ($MN)
14 Global In Vitro Diagnostics Market Outlook, By Instruments (2013-2022) ($MN)
15 Global In Vitro Diagnostics Market Outlook, By Reagents & Kits (2013-2022) ($MN)
16 Global In Vitro Diagnostics Market Outlook, By Services (2013-2022) ($MN)
17 Global In Vitro Diagnostics Market Outlook, By Technology (2013-2022) ($MN)
18 Global In Vitro Diagnostics Market Outlook, By Immunochemistry/Immunoassays (2013-2022) ($MN)
19 Global In Vitro Diagnostics Market Outlook, By Elisa (2013-2022) ($MN)
20 Global In Vitro Diagnostics Market Outlook, By Western Blot (2013-2022) ($MN)
21 Global In Vitro Diagnostics Market Outlook, By Rapid Tests (2013-2022) ($MN)
22 Global In Vitro Diagnostics Market Outlook, By Radioimmunoassays (RIA) (2013-2022) ($MN)
23 Global In Vitro Diagnostics Market Outlook, By Elispot (2013-2022) ($MN)
24 Global In Vitro Diagnostics Market Outlook, By Coagulation and Hemostasis (2013-2022) ($MN)
25 Global In Vitro Diagnostics Market Outlook, By Molecular Diagnostics (MDX) (2013-2022) ($MN)
26 Global In Vitro Diagnostics Market Outlook, By DNA Sequencing & Next-Generation Sequencing (2013-2022) ($MN)
27 Global In Vitro Diagnostics Market Outlook, By Hybridization (2013-2022) ($MN)
28 Global In Vitro Diagnostics Market Outlook, By Isothermal Nucleic Acid Amplification Technology (INAAT) (2013-2022) ($MN)
29 Global In Vitro Diagnostics Market Outlook, By Microarrays (2013-2022) ($MN)
30 Global In Vitro Diagnostics Market Outlook, By Polymerase Chain Reaction (PCR) (2013-2022) ($MN)
31 Global In Vitro Diagnostics Market Outlook, By Other Molecular Diagnostics (2013-2022) ($MN)
32 Global In Vitro Diagnostics Market Outlook, By Hematology (2013-2022) ($MN)
33 Global In Vitro Diagnostics Market Outlook, By Microbiology (2013-2022) ($MN)
34 Global In Vitro Diagnostics Market Outlook, By Clinical Chemistry (2013-2022) ($MN)
35 Global In Vitro Diagnostics Market Outlook, By Electrolyte Panels (2013-2022) ($MN)
36 Global In Vitro Diagnostics Market Outlook, By Basic Metabolic Panel (2013-2022) ($MN)
37 Global In Vitro Diagnostics Market Outlook, By Lipid Profiles (2013-2022) ($MN)
38 Global In Vitro Diagnostics Market Outlook, By Liver Panels (2013-2022) ($MN)
39 Global In Vitro Diagnostics Market Outlook, By Renal Profiles (2013-2022) ($MN)
40 Global In Vitro Diagnostics Market Outlook, By Specialty Chemical Tests (2013-2022) ($MN)
41 Global In Vitro Diagnostics Market Outlook, By Thyroid Function Panels (2013-2022) ($MN)
42 Global In Vitro Diagnostics Market Outlook, By Other Technologies(2013-2022) ($MN)
43 Global In Vitro Diagnostics Market Outlook, By End-User (2013-2022) ($MN)
44 Global In Vitro Diagnostics Market Outlook, By Academic Institutes (2013-2022) ($MN)
45 Global In Vitro Diagnostics Market Outlook, By Hospitals (2013-2022) ($MN)
46 Global In Vitro Diagnostics Market Outlook, By Laboratories (2013-2022) ($MN)
47 Global In Vitro Diagnostics Market Outlook, By Patient Self-Testing (2013-2022) ($MN)
48 Global In Vitro Diagnostics Market Outlook, By Point-Of-Care Testing (2013-2022) ($MN)
49 Global In Vitro Diagnostics Market Outlook, By Other End-Users (2013-2022) ($MN)
50 North America In Vitro Diagnostics Market Outlook, By Country (2013-2022) ($MN)
51 North America In Vitro Diagnostics Market Outlook, By Application (2013-2022) ($MN)
52 North America In Vitro Diagnostics Market Outlook, By Diabetes (2013-2022) ($MN)
53 North America In Vitro Diagnostics Market Outlook, By Autoimmune Diseases (2013-2022) ($MN)
54 North America In Vitro Diagnostics Market Outlook, By Cardiology (2013-2022) ($MN)
55 North America In Vitro Diagnostics Market Outlook, By Drug Testing (2013-2022) ($MN)
56 North America In Vitro Diagnostics Market Outlook, By HIV/AIDS (2013-2022) ($MN)
57 North America In Vitro Diagnostics Market Outlook, By Infectious Diseases (2013-2022) ($MN)
58 North America In Vitro Diagnostics Market Outlook, By Nephrology (2013-2022) ($MN)
59 North America In Vitro Diagnostics Market Outlook, By Oncology/Cancer (2013-2022) ($MN)
60 North America In Vitro Diagnostics Market Outlook, By Other Applications (2013-2022) ($MN)
61 North America In Vitro Diagnostics Market Outlook, By Product & Service (2013-2022) ($MN)
62 North America In Vitro Diagnostics Market Outlook, By Data Management Software/Hardware (2013-2022) ($MN)
63 North America In Vitro Diagnostics Market Outlook, By Instruments (2013-2022) ($MN)
64 North America In Vitro Diagnostics Market Outlook, By Reagents & Kits (2013-2022) ($MN)
65 North America In Vitro Diagnostics Market Outlook, By Services (2013-2022) ($MN)
66 North America In Vitro Diagnostics Market Outlook, By Technology (2013-2022) ($MN)
67 North America In Vitro Diagnostics Market Outlook, By Immunochemistry/Immunoassays (2013-2022) ($MN)
68 North America In Vitro Diagnostics Market Outlook, By Elisa (2013-2022) ($MN)
69 North America In Vitro Diagnostics Market Outlook, By Western Blot (2013-2022) ($MN)
70 North America In Vitro Diagnostics Market Outlook, By Rapid Tests (2013-2022) ($MN)
71 North America In Vitro Diagnostics Market Outlook, By Radioimmunoassays (RIA) (2013-2022) ($MN)
72 North America In Vitro Diagnostics Market Outlook, By Elispot (2013-2022) ($MN)
73 North America In Vitro Diagnostics Market Outlook, By Coagulation and Hemostasis (2013-2022) ($MN)
74 North America In Vitro Diagnostics Market Outlook, By Molecular Diagnostics (MDX) (2013-2022) ($MN)
75 North America In Vitro Diagnostics Market Outlook, By DNA Sequencing & Next-Generation Sequencing (2013-2022) ($MN)
76 North America In Vitro Diagnostics Market Outlook, By Hybridization (2013-2022) ($MN)
77 North America In Vitro Diagnostics Market Outlook, By Isothermal Nucleic Acid Amplification Technology (INAAT) (2013-2022) ($MN)
78 North America In Vitro Diagnostics Market Outlook, By Microarrays (2013-2022) ($MN)
79 North America In Vitro Diagnostics Market Outlook, By Polymerase Chain Reaction (PCR) (2013-2022) ($MN)
80 North America In Vitro Diagnostics Market Outlook, By Other Molecular Diagnostics (2013-2022) ($MN)
81 North America In Vitro Diagnostics Market Outlook, By Hematology (2013-2022) ($MN)
82 North America In Vitro Diagnostics Market Outlook, By Microbiology (2013-2022) ($MN)
83 North America In Vitro Diagnostics Market Outlook, By Clinical Chemistry (2013-2022) ($MN)
84 North America In Vitro Diagnostics Market Outlook, By Electrolyte Panels (2013-2022) ($MN)
85 North America In Vitro Diagnostics Market Outlook, By Basic Metabolic Panel (2013-2022) ($MN)
86 North America In Vitro Diagnostics Market Outlook, By Lipid Profiles (2013-2022) ($MN)
87 North America In Vitro Diagnostics Market Outlook, By Liver Panels (2013-2022) ($MN)
88 North America In Vitro Diagnostics Market Outlook, By Renal Profiles (2013-2022) ($MN)
89 North America In Vitro Diagnostics Market Outlook, By Specialty Chemical Tests (2013-2022) ($MN)
90 North America In Vitro Diagnostics Market Outlook, By Thyroid Function Panels (2013-2022) ($MN)
91 North America In Vitro Diagnostics Market Outlook, By Other Technologies(2013-2022) ($MN)
92 North America In Vitro Diagnostics Market Outlook, By End-User (2013-2022) ($MN)
93 North America In Vitro Diagnostics Market Outlook, By Academic Institutes (2013-2022) ($MN)
94 North America In Vitro Diagnostics Market Outlook, By Hospitals (2013-2022) ($MN)
95 North America In Vitro Diagnostics Market Outlook, By Laboratories (2013-2022) ($MN)
96 North America In Vitro Diagnostics Market Outlook, By Patient Self-Testing (2013-2022) ($MN)
97 North America In Vitro Diagnostics Market Outlook, By Point-Of-Care Testing (2013-2022) ($MN)
98 North America In Vitro Diagnostics Market Outlook, By Other End-Users (2013-2022) ($MN)
99 Europe In Vitro Diagnostics Market Outlook, By Country (2013-2022) ($MN)
100 Europe In Vitro Diagnostics Market Outlook, By Application (2013-2022) ($MN)
101 Europe In Vitro Diagnostics Market Outlook, By Diabetes (2013-2022) ($MN)
102 Europe In Vitro Diagnostics Market Outlook, By Autoimmune Diseases (2013-2022) ($MN)
103 Europe In Vitro Diagnostics Market Outlook, By Cardiology (2013-2022) ($MN)
104 Europe In Vitro Diagnostics Market Outlook, By Drug Testing (2013-2022) ($MN)
105 Europe In Vitro Diagnostics Market Outlook, By HIV/AIDS (2013-2022) ($MN)
106 Europe In Vitro Diagnostics Market Outlook, By Infectious Diseases (2013-2022) ($MN)
107 Europe In Vitro Diagnostics Market Outlook, By Nephrology (2013-2022) ($MN)
108 Europe In Vitro Diagnostics Market Outlook, By Oncology/Cancer (2013-2022) ($MN)
109 Europe In Vitro Diagnostics Market Outlook, By Other Applications (2013-2022) ($MN)
110 Europe In Vitro Diagnostics Market Outlook, By Product & Service (2013-2022) ($MN)
111 Europe In Vitro Diagnostics Market Outlook, By Data Management Software/Hardware (2013-2022) ($MN)
112 Europe In Vitro Diagnostics Market Outlook, By Instruments (2013-2022) ($MN)
113 Europe In Vitro Diagnostics Market Outlook, By Reagents & Kits (2013-2022) ($MN)
114 Europe In Vitro Diagnostics Market Outlook, By Services (2013-2022) ($MN)
115 Europe In Vitro Diagnostics Market Outlook, By Technology (2013-2022) ($MN)
116 Europe In Vitro Diagnostics Market Outlook, By Immunochemistry/Immunoassays (2013-2022) ($MN)
117 Europe In Vitro Diagnostics Market Outlook, By Elisa (2013-2022) ($MN)
118 Europe In Vitro Diagnostics Market Outlook, By Western Blot (2013-2022) ($MN)
119 Europe In Vitro Diagnostics Market Outlook, By Rapid Tests (2013-2022) ($MN)
120 Europe In Vitro Diagnostics Market Outlook, By Radioimmunoassays (RIA) (2013-2022) ($MN)
121 Europe In Vitro Diagnostics Market Outlook, By Elispot (2013-2022) ($MN)
122 Europe In Vitro Diagnostics Market Outlook, By Coagulation and Hemostasis (2013-2022) ($MN)
123 Europe In Vitro Diagnostics Market Outlook, By Molecular Diagnostics (MDX) (2013-2022) ($MN)
124 Europe In Vitro Diagnostics Market Outlook, By DNA Sequencing & Next-Generation Sequencing (2013-2022) ($MN)
125 Europe In Vitro Diagnostics Market Outlook, By Hybridization (2013-2022) ($MN)
126 Europe In Vitro Diagnostics Market Outlook, By Isothermal Nucleic Acid Amplification Technology (INAAT) (2013-2022) ($MN)
127 Europe In Vitro Diagnostics Market Outlook, By Microarrays (2013-2022) ($MN)
128 Europe In Vitro Diagnostics Market Outlook, By Polymerase Chain Reaction (PCR) (2013-2022) ($MN)
129 Europe In Vitro Diagnostics Market Outlook, By Other Molecular Diagnostics (2013-2022) ($MN)
130 Europe In Vitro Diagnostics Market Outlook, By Hematology (2013-2022) ($MN)
131 Europe In Vitro Diagnostics Market Outlook, By Microbiology (2013-2022) ($MN)
132 Europe In Vitro Diagnostics Market Outlook, By Clinical Chemistry (2013-2022) ($MN)
133 Europe In Vitro Diagnostics Market Outlook, By Electrolyte Panels (2013-2022) ($MN)
134 Europe In Vitro Diagnostics Market Outlook, By Basic Metabolic Panel (2013-2022) ($MN)
135 Europe In Vitro Diagnostics Market Outlook, By Lipid Profiles (2013-2022) ($MN)
136 Europe In Vitro Diagnostics Market Outlook, By Liver Panels (2013-2022) ($MN)
137 Europe In Vitro Diagnostics Market Outlook, By Renal Profiles (2013-2022) ($MN)
138 Europe In Vitro Diagnostics Market Outlook, By Specialty Chemical Tests (2013-2022) ($MN)
139 Europe In Vitro Diagnostics Market Outlook, By Thyroid Function Panels (2013-2022) ($MN)
140 Europe In Vitro Diagnostics Market Outlook, By Other Technologies(2013-2022) ($MN)
141 Europe In Vitro Diagnostics Market Outlook, By End-User (2013-2022) ($MN)
142 Europe In Vitro Diagnostics Market Outlook, By Academic Institutes (2013-2022) ($MN)
143 Europe In Vitro Diagnostics Market Outlook, By Hospitals (2013-2022) ($MN)
144 Europe In Vitro Diagnostics Market Outlook, By Laboratories (2013-2022) ($MN)
145 Europe In Vitro Diagnostics Market Outlook, By Patient Self-Testing (2013-2022) ($MN)
146 Europe In Vitro Diagnostics Market Outlook, By Point-Of-Care Testing (2013-2022) ($MN)
147 Europe In Vitro Diagnostics Market Outlook, By Other End-Users (2013-2022) ($MN)
148 Asia Pacific In Vitro Diagnostics Market Outlook, By Country (2013-2022) ($MN)
149 Asia Pacific In Vitro Diagnostics Market Outlook, By Application (2013-2022) ($MN)
150 Asia Pacific In Vitro Diagnostics Market Outlook, By Diabetes (2013-2022) ($MN)
151 Asia Pacific In Vitro Diagnostics Market Outlook, By Autoimmune Diseases (2013-2022) ($MN)
152 Asia Pacific In Vitro Diagnostics Market Outlook, By Cardiology (2013-2022) ($MN)
153 Asia Pacific In Vitro Diagnostics Market Outlook, By Drug Testing (2013-2022) ($MN)
154 Asia Pacific In Vitro Diagnostics Market Outlook, By HIV/AIDS (2013-2022) ($MN)
155 Asia Pacific In Vitro Diagnostics Market Outlook, By Infectious Diseases (2013-2022) ($MN)
156 Asia Pacific In Vitro Diagnostics Market Outlook, By Nephrology (2013-2022) ($MN)
157 Asia Pacific In Vitro Diagnostics Market Outlook, By Oncology/Cancer (2013-2022) ($MN)
158 Asia Pacific In Vitro Diagnostics Market Outlook, By Other Applications (2013-2022) ($MN)
159 Asia Pacific In Vitro Diagnostics Market Outlook, By Product & Service (2013-2022) ($MN)
160 Asia Pacific In Vitro Diagnostics Market Outlook, By Data Management Software/Hardware (2013-2022) ($MN)
161 Asia Pacific In Vitro Diagnostics Market Outlook, By Instruments (2013-2022) ($MN)
162 Asia Pacific In Vitro Diagnostics Market Outlook, By Reagents & Kits (2013-2022) ($MN)
163 Asia Pacific In Vitro Diagnostics Market Outlook, By Services (2013-2022) ($MN)
164 Asia Pacific In Vitro Diagnostics Market Outlook, By Technology (2013-2022) ($MN)
165 Asia Pacific In Vitro Diagnostics Market Outlook, By Immunochemistry/Immunoassays (2013-2022) ($MN)
166 Asia Pacific In Vitro Diagnostics Market Outlook, By Elisa (2013-2022) ($MN)
167 Asia Pacific In Vitro Diagnostics Market Outlook, By Western Blot (2013-2022) ($MN)
168 Asia Pacific In Vitro Diagnostics Market Outlook, By Rapid Tests (2013-2022) ($MN)
169 Asia Pacific In Vitro Diagnostics Market Outlook, By Radioimmunoassays (RIA) (2013-2022) ($MN)
170 Asia Pacific In Vitro Diagnostics Market Outlook, By Elispot (2013-2022) ($MN)
171 Asia Pacific In Vitro Diagnostics Market Outlook, By Coagulation and Hemostasis (2013-2022) ($MN)
172 Asia Pacific In Vitro Diagnostics Market Outlook, By Molecular Diagnostics (MDX) (2013-2022) ($MN)
173 Asia Pacific In Vitro Diagnostics Market Outlook, By DNA Sequencing & Next-Generation Sequencing (2013-2022) ($MN)
174 Asia Pacific In Vitro Diagnostics Market Outlook, By Hybridization (2013-2022) ($MN)
175 Asia Pacific In Vitro Diagnostics Market Outlook, By Isothermal Nucleic Acid Amplification Technology (INAAT) (2013-2022) ($MN)
176 Asia Pacific In Vitro Diagnostics Market Outlook, By Microarrays (2013-2022) ($MN)
177 Asia Pacific In Vitro Diagnostics Market Outlook, By Polymerase Chain Reaction (PCR) (2013-2022) ($MN)
178 Asia Pacific In Vitro Diagnostics Market Outlook, By Other Molecular Diagnostics (2013-2022) ($MN)
179 Asia Pacific In Vitro Diagnostics Market Outlook, By Hematology (2013-2022) ($MN)
180 Asia Pacific In Vitro Diagnostics Market Outlook, By Microbiology (2013-2022) ($MN)
181 Asia Pacific In Vitro Diagnostics Market Outlook, By Clinical Chemistry (2013-2022) ($MN)
182 Asia Pacific In Vitro Diagnostics Market Outlook, By Electrolyte Panels (2013-2022) ($MN)
183 Asia Pacific In Vitro Diagnostics Market Outlook, By Basic Metabolic Panel (2013-2022) ($MN)
184 Asia Pacific In Vitro Diagnostics Market Outlook, By Lipid Profiles (2013-2022) ($MN)
185 Asia Pacific In Vitro Diagnostics Market Outlook, By Liver Panels (2013-2022) ($MN)
186 Asia Pacific In Vitro Diagnostics Market Outlook, By Renal Profiles (2013-2022) ($MN)
187 Asia Pacific In Vitro Diagnostics Market Outlook, By Specialty Chemical Tests (2013-2022) ($MN)
188 Asia Pacific In Vitro Diagnostics Market Outlook, By Thyroid Function Panels (2013-2022) ($MN)
189 Asia Pacific In Vitro Diagnostics Market Outlook, By Other Technologies(2013-2022) ($MN)
190 Asia Pacific In Vitro Diagnostics Market Outlook, By End-User (2013-2022) ($MN)
191 Asia Pacific In Vitro Diagnostics Market Outlook, By Academic Institutes (2013-2022) ($MN)
192 Asia Pacific In Vitro Diagnostics Market Outlook, By Hospitals (2013-2022) ($MN)
193 Asia Pacific In Vitro Diagnostics Market Outlook, By Laboratories (2013-2022) ($MN)
194 Asia Pacific In Vitro Diagnostics Market Outlook, By Patient Self-Testing (2013-2022) ($MN)
195 Asia Pacific In Vitro Diagnostics Market Outlook, By Point-Of-Care Testing (2013-2022) ($MN)
196 Asia Pacific In Vitro Diagnostics Market Outlook, By Other End-Users (2013-2022) ($MN)
197 RoW In Vitro Diagnostics Market Outlook, By Country (2013-2022) ($MN)
198 RoW In Vitro Diagnostics Market Outlook, By Application (2013-2022) ($MN)
199 RoW In Vitro Diagnostics Market Outlook, By Diabetes (2013-2022) ($MN)
200 RoW In Vitro Diagnostics Market Outlook, By Autoimmune Diseases (2013-2022) ($MN)
201 RoW In Vitro Diagnostics Market Outlook, By Cardiology (2013-2022) ($MN)
202 RoW In Vitro Diagnostics Market Outlook, By Drug Testing (2013-2022) ($MN)
203 RoW In Vitro Diagnostics Market Outlook, By HIV/AIDS (2013-2022) ($MN)
204 RoW In Vitro Diagnostics Market Outlook, By Infectious Diseases (2013-2022) ($MN)
205 RoW In Vitro Diagnostics Market Outlook, By Nephrology (2013-2022) ($MN)
206 RoW In Vitro Diagnostics Market Outlook, By Oncology/Cancer (2013-2022) ($MN)
207 RoW In Vitro Diagnostics Market Outlook, By Other Applications (2013-2022) ($MN)
208 RoW In Vitro Diagnostics Market Outlook, By Product & Service (2013-2022) ($MN)
209 RoW In Vitro Diagnostics Market Outlook, By Data Management Software/Hardware (2013-2022) ($MN)
210 RoW In Vitro Diagnostics Market Outlook, By Instruments (2013-2022) ($MN)
211 RoW In Vitro Diagnostics Market Outlook, By Reagents & Kits (2013-2022) ($MN)
212 RoW In Vitro Diagnostics Market Outlook, By Services (2013-2022) ($MN)
213 RoW In Vitro Diagnostics Market Outlook, By Technology (2013-2022) ($MN)
214 RoW In Vitro Diagnostics Market Outlook, By Immunochemistry/Immunoassays (2013-2022) ($MN)
215 RoW In Vitro Diagnostics Market Outlook, By Elisa (2013-2022) ($MN)
216 RoW In Vitro Diagnostics Market Outlook, By Western Blot (2013-2022) ($MN)
217 RoW In Vitro Diagnostics Market Outlook, By Rapid Tests (2013-2022) ($MN)
218 RoW In Vitro Diagnostics Market Outlook, By Radioimmunoassays (RIA) (2013-2022) ($MN)
219 RoW In Vitro Diagnostics Market Outlook, By Elispot (2013-2022) ($MN)
220 RoW In Vitro Diagnostics Market Outlook, By Coagulation and Hemostasis (2013-2022) ($MN)
221 RoW In Vitro Diagnostics Market Outlook, By Molecular Diagnostics (MDX) (2013-2022) ($MN)
222 RoW In Vitro Diagnostics Market Outlook, By DNA Sequencing & Next-Generation Sequencing (2013-2022) ($MN)
223 RoW In Vitro Diagnostics Market Outlook, By Hybridization (2013-2022) ($MN)
224 RoW In Vitro Diagnostics Market Outlook, By Isothermal Nucleic Acid Amplification Technology (INAAT) (2013-2022) ($MN)
225 RoW In Vitro Diagnostics Market Outlook, By Microarrays (2013-2022) ($MN)
226 RoW In Vitro Diagnostics Market Outlook, By Polymerase Chain Reaction (PCR) (2013-2022) ($MN)
227 RoW In Vitro Diagnostics Market Outlook, By Other Molecular Diagnostics (2013-2022) ($MN)
228 RoW In Vitro Diagnostics Market Outlook, By Hematology (2013-2022) ($MN)
229 RoW In Vitro Diagnostics Market Outlook, By Microbiology (2013-2022) ($MN)
230 RoW In Vitro Diagnostics Market Outlook, By Clinical Chemistry (2013-2022) ($MN)
231 RoW In Vitro Diagnostics Market Outlook, By Electrolyte Panels (2013-2022) ($MN)
232 RoW In Vitro Diagnostics Market Outlook, By Basic Metabolic Panel (2013-2022) ($MN)
233 RoW In Vitro Diagnostics Market Outlook, By Lipid Profiles (2013-2022) ($MN)
234 RoW In Vitro Diagnostics Market Outlook, By Liver Panels (2013-2022) ($MN)
235 RoW In Vitro Diagnostics Market Outlook, By Renal Profiles (2013-2022) ($MN)
236 RoW In Vitro Diagnostics Market Outlook, By Specialty Chemical Tests (2013-2022) ($MN)
237 RoW In Vitro Diagnostics Market Outlook, By Thyroid Function Panels (2013-2022) ($MN)
238 RoW In Vitro Diagnostics Market Outlook, By Other Technologies(2013-2022) ($MN)
239 RoW In Vitro Diagnostics Market Outlook, By End-User (2013-2022) ($MN)
240 RoW In Vitro Diagnostics Market Outlook, By Academic Institutes (2013-2022) ($MN)
241 RoW In Vitro Diagnostics Market Outlook, By Hospitals (2013-2022) ($MN)
242 RoW In Vitro Diagnostics Market Outlook, By Laboratories (2013-2022) ($MN)
243 RoW In Vitro Diagnostics Market Outlook, By Patient Self-Testing (2013-2022) ($MN)
244 RoW In Vitro Diagnostics Market Outlook, By Point-Of-Care Testing (2013-2022) ($MN)
245 RoW In Vitro Diagnostics Market Outlook, By Other End-Users (2013-2022) ($MN)
